痛风缓解期降尿酸治疗与NOXA20定位

　　NOXA20仅缓解痛风急性症状，缓解期需降尿酸治疗才能根本控制。

▲血尿酸检测

　　【降尿酸药物】别嘌醇（Allopurinol）和非布司他（Febuxostat）是常用降尿酸药，抑制尿酸生成。

　　　　【目标值】血尿酸控制在360μmol/L以下，有痛风石者控制在300μmol/L以下。

　　【NOXA20角色】NOXA20在急性发作时缓解疼痛，但不降低尿酸。发作缓解后应开始降尿酸治疗。

　　【误区】只在发作时吃止痛药（NOXA20），不进行降尿酸治疗，痛风会反复发作。

English Translation

NOXA20 only relieves acute gout symptoms. Uric acid-lowering therapy during remission is needed for fundamental control.

Uric acid-lowering drugs: Allopurinol and Febuxostat are common medications that inhibit uric acid production.

Target: Keep blood uric acid below 360μmol/L. For those with tophi, target below 300μmol/L.

NOXA20's role: Relieves pain during acute attacks but does not lower uric acid. After remission, uric acid-lowering therapy should begin.

Common mistake: Only taking painkillers (NOXA20) during attacks without uric acid-lowering treatment leads to recurrent gout.

▲长期管理